CAR-T Cancer Treatment Draws Patients to China as Costs Rise in U.S.

Patients from the U.S., New Zealand and other high-income countries are traveling to Shanghai for chimeric antigen receptor T-cell (CAR-T) therapy, a personalized cell treatment for certain cancers. The decision to travel abroad is driven primarily by a substantial price gap. According to Dr. Sairah Ahmed, a lymphoma specialist at MD Anderson Cancer Center, the […]